Haemostatic and rheological factors as predictors of restenosis following percutaneous transluminal angioplasty

European Journal of Vascular and Endovascular Surgery

Volumn 14, Issue 5, 1997, Pages 392-398

  Price, J F ^a   Mamode, N ^a   Smith, F B ^a   Woodburn, K R ^a   Rumley, A ^a   Lowe, G D O ^a   Fowkes, F G R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Angioplasty; Fibrinogen; Haemostatic factors; Peripheral arterial disease; Restenosis; Rheology

Indexed keywords

FIBRIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD RHEOLOGY; CLINICAL TRIAL; ECHOGRAPHY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEMATOCRIT; HEMOSTASIS; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMA VISCOSITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTENOSIS; SMOKING HABIT; UNITED KINGDOM;

EID: 0030729408     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(97)80290-0     Document Type: Article

References (36)

1. Price JF Fowkes FGR Effectiveness of percutaneous transluminal angioplasty for lower limb atherosclerosis Greenhalgh Fowkes Trials and Tribulations of Vascular Surgery 1996 W.B. Saunders Co. London 245 257
2. Hermans WRM Rensing BJ Strauss BH Serruys PW Prevention of restenosis after percutaneous transluminal coronary angioplasty: The search for a “magic bullet” Am Heart J 122 1991 171 187
3. Lowe GDO Fowkes FGR Dawes J Donnan PT Lennie SE Housley E Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study Circulation 87 1993 1915 1920
4. Smith FB Lowe GDO Fowkes FGR Rumley A Rumley AG Donnan PT Housley E Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease Atherosclerosis 102 1993 155 162
5. Lee AJ Fowkes FGR Lowe GDO Rumley A Fibrin D-dimer, haemostatic factors and peripheral arterial disease Thromb Haemost 74 1995 828 832
6. Lee AJ Fowkes FGR Rattray A Rumley A Lowe GDO Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease Br J Haematol 92 1996 226 230
7. Glagov S Intimal hyperplasia, vascular modelling, and restenosis problem Circulation 89 1994 2888 2891
8. Haudenschild CC Pathobiology of restenosis after angioplasty Am J Med 94 Suppl. 4A 1993 40S 44S
9. Collen D Report of the meeting of the Subcommittee on Fibrinolysis San Diego, July 13, 1985 Thromb Haemost 54 1985 893
10. De Groot PG Sixma JJ Role of von Willebrand factor in the vessel wall Semin Thromb Hemost 13 1987 416 424
11. Dang CV Bell WR The normal and morbid biology of fibrinogen Am J Med 87 1989 567
12. Lip GHY Lowe GDO Fibrin D-dimer; a useful clinical marker of thrombogenesis Clin Sci 89 1995 205 214
13. Lowe GDO Blood viscosity and cardiovascular disease Thromb Haemost 67 1992 494 498
14. Smith FB Lee AJ Fowkes FGR Lowe GDO Rumley A Smoking, haemostatic factors and severity of aorto-iliac and femoro-popliteal disease Thromb Haemost 75 1996 19 24
15. Jager KA Phillips DJ Martin RL Non-invasive mapping of lower limb arterial lesions Ultrasound Med Biol 11 1985 515 521
16. Jeans WD Armstrong S Cole SEA Horrocks M Baird RN Fate of patients undergoing transluminal angioplasty for lower limb ischaemia Radiology 177 1990 559 564
17. Spence RK Freiman DB Gatenby R Long-term results of transluminal angioplasty of the iliac and femoral arteries Arch Surg 116 1981 1377 1386
18. Capek P McLean GK Berkowitz HD Femoropopliteal angioplasty. Factors influencing long-term success Circulation 83 Suppl. I 1991 170 180
19. Becquemin JP Cavillon A Haiduc F Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome J Vasc Surg 19 1994 495 502
20. Johnston KW Rae M Hogg-Johnston SA Five year results of a prospective study of percutaneous transluminal angioplasty Ann Surg 206 1987 403 413
21. Huber K Jörg M Probst P Schuster E Lang I Kaindl F Binder BR A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis Thromb Haemost 67 1992 209 213
22. Brack MJ More R Pringle S Gershlick AH Absence of a prothrombotic state in restenotic patients? Coronary Artery Disease 5 1994 501 506
23. Montalescot G Ankri A Vicaut E Drobinski G Grosgogeat Y Thomas D Fibrinogen after coronary angioplasty as a risk factor for restenosis Circulation 92 1995 31 38
24. Shah PK Amin J Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty Circulation 85 1992 1279 1285
25. (abstract) Kannel WB D'Agostino RB Update of fibrinogen as a major cardiovascular risk factor; the Framingham Study J Am Coll Cardiol 15 1990 156A
26. Woodburn KR Lowe GDO Rumley A Love J Pollock JG Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive diseases Int Angiol 14 1995 346 352
27. Matsi PJ Manninen HI Laakso M Jaakkola P Impact of risk factors on limb salvage after angioplasty in chronic critical lower limb ischaemia Angiology 45 1994 797 804
28. Benchimol D Bonnet J Benchimol H Drouillet F Duplaa C Couffinhal T Desgranges C Bricaud H Biological risk factors for restenosis after percutaneous transluminal angioplasty Int J Cardiol 38 1993 7 18
29. Banerjee AK Pearson J Gilliland EL A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants Thromb Haemost 68 1992 261 263
30. Fowkes FGR Lowe GDO Housley E Cross linked fibrin degradation products, progression of peripheral arterial disease and risk of coronary heart disease Lancet 342 1993 84 86
31. Lowe GDO Rumley A Yarnell JWG Sweetnam PM Thomas HF Fibrin D-dimer, von Willebrand factor and tissue plasminogen activator antigens are predictors of major ischaemic heart disease: the Caerphilly Study Blood Coag Fibrinolysis 6 1995 156 157
32. Jørgensen B Nielsen JD Nørgård J Helligsø P B˦kgaard R Egeblad M Cross-linked fibrin degredation products (XLFDP) as marker of early rethrombosis in percutaneous transluminal angioplasty Eur J Vasc Surg 7 1993 720 724
33. Lowe GDO Lee AJ Rumley A Price JF Fowkes FGR Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study Br J Haematol 96 1997 168 173
34. Leng GC Colour duplex ultrasound The Measurement of Peripheral Vascular Disease in Epidemiological Surveys M.D. Thesis 1993 University of Edinburgh 139 175
35. Wiseman S Kenchington G Dain R Influence of smoking and plasma factors on patency of femoropopliteal vein grafts BMJ 299 1989 643 646
36. Woodburn KR Rumley A Love J Murray GD Lowe GDO Clinical, biochemical and rheological factors affecting the outcome of infra-inguinal bypass grafting J Vasc Surg 24 1996 639 646